GPR150

gene
On this page

Also known as PGR11

Summary

GPR150 (G protein-coupled receptor 150, HGNC:23628) is a protein-coding gene on chromosome 5q15, encoding Probable G-protein coupled receptor 150 (Q8NGU9). Orphan receptor.

This gene encodes an orphan member of the class A rhodopsin-like family of G-protein-coupled receptors (GPCRs). Within the rhodopsin-like family, this gene is a member of the vasopressin-like subfamily that also includes vasopressin and oxytocin receptors. The silencing of this gene, due to promoter methylation, is associated with ovarian cancer progression. All GPCRs have a transmembrane domain that includes seven transmembrane alpha-helices. A general feature of GPCR signaling is the agonist-induced conformational change in the receptor, leading to activation of the heterotrimeric G protein. The activated G protein then binds to and activates numerous downstream effector proteins, which generate second messengers that mediate a broad range of cellular and physiological processes.

Source: NCBI Gene 285601 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 79 total
  • Druggable target: yes
  • MANE Select transcript: NM_199243

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:23628
Approved symbolGPR150
NameG protein-coupled receptor 150
Location5q15
Locus typegene with protein product
StatusApproved
AliasesPGR11
Ensembl geneENSG00000178015
Ensembl biotypeprotein_coding
Entrez285601

Gene structure

Transcript identifiers

Ensembl transcripts: 1 — 1 protein_coding

ENST00000380007

RefSeq mRNA: 1 — MANE Select: NM_199243 NM_199243

CCDS: CCDS4074

Canonical transcript exons

ENST00000380007 — 1 exons

ExonStartEnd
ENSE000014833579562008795622142

Expression profiles

Bgee: expression breadth ubiquitous, 101 present calls, max score 72.30.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.2821 / max 11.9813, expressed in 127 samples.

FANTOM5 promoters (2 alternative TSS)

Promoter IDTPM avgSamples expressed
576240.145776
576230.136570

Top tissues by expression

121 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
body of pancreasUBERON:000115072.30gold quality
stromal cell of endometriumCL:000225570.08gold quality
Brodmann (1909) area 9UBERON:001354067.22gold quality
superior frontal gyrusUBERON:000266167.16gold quality
prefrontal cortexUBERON:000045166.03gold quality
dorsolateral prefrontal cortexUBERON:000983465.42gold quality
pancreasUBERON:000126464.93gold quality
frontal cortexUBERON:000187064.38gold quality
anterior cingulate cortexUBERON:000983562.87gold quality
right frontal lobeUBERON:000281061.84gold quality
cerebral cortexUBERON:000095661.52gold quality
primary visual cortexUBERON:000243660.03gold quality
body of stomachUBERON:000116158.36gold quality
fundus of stomachUBERON:000116055.63gold quality
subcutaneous adipose tissueUBERON:000219055.35gold quality
stomachUBERON:000094553.99gold quality
temporal lobeUBERON:000187153.17gold quality
amygdalaUBERON:000187652.94gold quality
tibial nerveUBERON:000132352.34gold quality
brainUBERON:000095552.03gold quality
granulocyteCL:000009451.95gold quality
left coronary arteryUBERON:000162651.14gold quality
adipose tissueUBERON:000101350.91gold quality
islet of LangerhansUBERON:000000650.89gold quality
lymph nodeUBERON:000002950.62gold quality
placentaUBERON:000198750.09gold quality
hypothalamusUBERON:000189850.05gold quality
nucleus accumbensUBERON:000188249.89gold quality
popliteal arteryUBERON:000225049.53gold quality
tibial arteryUBERON:000761049.51gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no1.13

Regulation

Is transcription factor: no

Cross-species orthologs

2 orthologs

OrganismSymbolGene ID
drosophila_melanogasterCrzRFBGN0036278
caenorhabditis_elegansWBGENE00013642

Paralogs (16): NPFFR2 (ENSG00000056291), GNRHR (ENSG00000109163), CCKBR (ENSG00000110148), HCRTR1 (ENSG00000121764), AVPR2 (ENSG00000126895), GALR3 (ENSG00000128310), HCRTR2 (ENSG00000137252), NPFFR1 (ENSG00000148734), CCKAR (ENSG00000163394), AVPR1A (ENSG00000166148), GALR1 (ENSG00000166573), GPR22 (ENSG00000172209), OXTR (ENSG00000180914), FFAR4 (ENSG00000186188), QRFPR (ENSG00000186867), AVPR1B (ENSG00000198049)

Protein

Protein identifiers

Probable G-protein coupled receptor 150Q8NGU9 (reviewed: Q8NGU9)

All UniProt accessions (1): Q8NGU9

UniProt curated annotations — full annotation on UniProt →

Function. Orphan receptor.

Subcellular location. Cell membrane.

Similarity. Belongs to the G-protein coupled receptor 1 family.

RefSeq proteins (1): NP_954713* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR000276GPCR_RhodpsnFamily
IPR017452GPCR_Rhodpsn_7TMDomain

Pfam: PF00001

UniProt features (21 total): topological domain 8, transmembrane region 7, compositionally biased region 3, region of interest 2, chain 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q8NGU9-F171.040.34

Function

Pathways and Gene Ontology

Reactome pathways

1 pathways

IDPathway
R-HSA-418555G alpha (s) signalling events

MSigDB gene sets: 45 (showing top): BENPORATH_ES_WITH_H3K27ME3, NFKB_Q6, GOBP_CELLULAR_RESPONSE_TO_HORMONE_STIMULUS, GOBP_RESPONSE_TO_HORMONE, RYTTCCTG_ETS2_B, HOXA4_Q2, YNGTTNNNATT_UNKNOWN, chr5q15, TGGAAA_NFAT_Q4_01, AP1FJ_Q2, ETS_Q4, GOMF_TRANSMEMBRANE_SIGNALING_RECEPTOR_ACTIVITY, GOMF_G_PROTEIN_COUPLED_RECEPTOR_ACTIVITY, MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3, MEISSNER_NPC_HCP_WITH_H3K4ME2

GO Biological Process (3): G protein-coupled receptor signaling pathway (GO:0007186), cellular response to hormone stimulus (GO:0032870), signal transduction (GO:0007165)

GO Molecular Function (1): G protein-coupled receptor activity (GO:0004930)

GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)

Reactome top-level categories

Rollup of top-1 pathways:

CategoryPathways
GPCR downstream signalling1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
G protein-coupled receptor activity1
signal transduction1
response to hormone1
cellular response to chemical stimulus1
cellular response to endogenous stimulus1
cell communication1
cellular process1
signaling1
regulation of cellular process1
cellular response to stimulus1
transmembrane signaling receptor activity1
G protein-coupled receptor signaling pathway1
membrane1
cell periphery1
cellular anatomical structure1

Protein interactions and networks

STRING

702 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
GPR150GPR162Q16538571
GPR150OXTP01178569
GPR150GNRH2O43555548
GPR150GPR176Q14439516
GPR150GPR88Q9GZN0513
GPR150GPR63Q9BZJ6501
GPR150GPR26Q8NDV2492
GPR150GPR82Q96P67491
GPR150GPR52Q9Y2T5486
GPR150GPR83Q9NYM4485
GPR150GPR61Q9BZJ8474
GPR150GPR139Q6DWJ6468
GPR150GPR148Q8TDV2445
GPR150GPR101Q96P66444
GPR150GPR135Q8IZ08437

IntAct

3 interactions, top by confidence:

ABTypeScore
GPR150PIK3CApsi-mi:“MI:0914”(association)0.350
C10orf90GPR150psi-mi:“MI:0914”(association)0.350

BioGRID (9): INTS2 (Affinity Capture-MS), FANCL (Affinity Capture-MS), KLHL15 (Affinity Capture-MS), INTS1 (Affinity Capture-MS), PDXDC1 (Affinity Capture-MS), GPR150 (Affinity Capture-MS), PPTC7 (Affinity Capture-MS), PIK3CA (Affinity Capture-MS), ABHD17B (Affinity Capture-MS)

ESM2 similar proteins: A0A0U1RQ45, A0A0U1RQS6, A0A286YF58, A0A2R8YCJ5, A0A7I2V3R4, A2VDX9, A5D7M7, A5PJP1, A6NGB7, A6NKF7, A6NLJ0, A8MVW0, B2RU40, C9JH25, C9JTQ0, D4A9R4, P03971, P03972, P0DPE3, P27106, P27539, P79295, Q0VD38, Q14761, Q1HCM0, Q29RK8, Q29RM6, Q2M3V2, Q3SWY4, Q3TYP4, Q5BLP8, Q5T442, Q64697, Q674R7, Q6PEY1, Q6QNY0, Q6ZS72, Q80XF7, Q8BQU6, Q8C581

Diamond homologs: Q8BL07, Q8NGU9

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

79 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance73
Likely benign6
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

197 predictions. Top by Δscore:

VariantEffectΔscore
5:95621161:A:Gdonor_gain0.9800
5:95621234:G:GAdonor_gain0.9800
5:95621236:T:TAdonor_gain0.9800
5:95621233:T:TAdonor_gain0.9700
5:95621251:G:GTdonor_gain0.9600
5:95621237:C:CAdonor_gain0.9300
5:95621342:AGGC:Aacceptor_gain0.8700
5:95621342:AGGCG:Aacceptor_gain0.8700
5:95621343:GGCG:Gacceptor_gain0.8700
5:95621343:GGCGG:Gacceptor_gain0.8700
5:95621184:G:GGdonor_gain0.8600
5:95621263:G:GTdonor_gain0.8500
5:95621192:GC:Gdonor_gain0.8200
5:95621343:GGC:Gacceptor_gain0.8200
5:95621259:G:GTdonor_gain0.8000
5:95620966:GTC:Gdonor_gain0.7900
5:95620967:TCT:Tdonor_gain0.7900
5:95621338:TTCCA:Tacceptor_loss0.7900
5:95621339:TCCAG:Tacceptor_loss0.7900
5:95621340:CCAGG:Cacceptor_loss0.7900
5:95621341:CAGGC:Cacceptor_loss0.7900
5:95621342:A:AGacceptor_gain0.7900
5:95621342:A:Gacceptor_loss0.7900
5:95621343:G:GGacceptor_gain0.7900
5:95621343:G:GTacceptor_loss0.7900
5:95621181:GCT:Gdonor_gain0.7800
5:95621260:G:GTdonor_gain0.7800
5:95621183:T:TGdonor_gain0.7600
5:95621186:T:Adonor_gain0.7600
5:95621191:GGC:Gdonor_gain0.7600

AlphaMissense

2684 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
5:95621164:A:CS297R0.978
5:95621166:C:AS297R0.978
5:95621166:C:GS297R0.978
5:95620936:T:CF221L0.957
5:95620938:C:AF221L0.957
5:95620938:C:GF221L0.957
5:95620937:T:GF221C0.955
5:95620780:T:AW169R0.953
5:95620780:T:CW169R0.953
5:95621575:T:CF434L0.951
5:95621577:C:AF434L0.951
5:95621577:C:GF434L0.951
5:95621152:A:CS293R0.945
5:95621154:C:AS293R0.945
5:95621154:C:GS293R0.945
5:95620956:G:CW227C0.931
5:95620956:G:TW227C0.931
5:95620996:T:CF241L0.931
5:95620998:C:AF241L0.931
5:95620998:C:GF241L0.931
5:95620553:A:TD93V0.929
5:95620777:G:CG168R0.921
5:95620455:C:AN60K0.920
5:95620455:C:GN60K0.920
5:95621338:T:CF355L0.915
5:95621340:C:AF355L0.915
5:95621340:C:GF355L0.915
5:95620553:A:CD93A0.907
5:95621327:T:AV351D0.903
5:95620554:C:AD93E0.896

dbSNP variants (sampled 300 via entrez): RS1000311297 (5:95619114 A>G), RS1000646336 (5:95620152 C>A), RS1000709356 (5:95618828 A>G,T), RS1001536102 (5:95619534 A>G), RS1001881986 (5:95619230 C>T), RS1002285896 (5:95620770 C>T), RS1002349881 (5:95622630 T>C), RS1003555427 (5:95622040 C>G), RS10038242 (5:95620079 A>G), RS1004246811 (5:95621909 G>A), RS1004341725 (5:95621525 G>A), RS1004446754 (5:95618120 A>G), RS1004497127 (5:95618414 A>G), RS1008721505 (5:95619913 G>C), RS1009210183 (5:95622365 C>G)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: yes

ChEMBL targets (1): CHEMBL4523898 (SINGLE PROTEIN)

PharmGKB: 1 entry (VIP=true, CPIC=false)

GtoPdb / IUPHAR curated pharmacology

(IUPHAR/BPS Guide to Pharmacology — expert-curated)

Target class: gpcr — Class A Orphans with no pharmacology

CTD chemical–gene interactions

13 total (human), top 13 by PubMed support.

ChemicalActions (top 5)PubMed papers
Valproic Aciddecreases expression, decreases methylation2
fluorene-9-bisphenolincreases expression1
terbufosincreases methylation1
arseniteincreases methylation1
Resveratrolaffects cotreatment, decreases expression1
Arsenicaffects methylation1
Benzo(a)pyreneincreases methylation1
Fonofosincreases methylation1
Parathionincreases methylation1
Plant Extractsaffects cotreatment, decreases expression1
Silicon Dioxidedecreases expression1
Smokedecreases expression1
Aflatoxin B1decreases expression1

ChEMBL screening assays

2 unique, capped per target: 2 binding

Representative assays (with source publication via chembl_document):

Assay IDTypeDescriptionSource paper
CHEMBL4883419BindingPRESTO-Tango GPCRome screening (GPR150)Data for DCP probe UCSF924

Cellosaurus cell lines

2 cell lines: 1 spontaneously immortalized cell line, 1 transformed cell line

First 10 cell lines (id-ordered, not curated):

CellosaurusNameCategorySex
CVCL_KX40PathHunter CHO-K1 GPR150 beta-arrestinSpontaneously immortalized cell lineFemale
CVCL_KZ52PathHunter HEK 293 GPR150 beta-arrestinTransformed cell lineFemale

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.